Skip to content

Botulinum toxin-induced uveitis in a patient with Behcet's disease under infliximab treatment: Case report

Botulinum toxin-induced uveitis in a patient with Behcet's disease under infliximab treatment: Case report - Botulinum toxin in Behcet's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000023887
Enrollment
1
Registered
2016-09-01
Start date
2016-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behcet&#39

Interventions

None listed

Sponsors

Department of Ophthalmology Asai hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A patient with Behcet's disease in which injections of botulinum toxin appeared to trigger uveitis even though his condition had been stable while he received periodic infliximab treatment.

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

MeasureTime frame
An ultra-widefield high-resolution digital image of fundus, anterior chamber flare, best corrected visual acuity, and intraocular pressure were measured before and after the Botulinum toxin-induced acute uveitis.

Countries

Japan

Contacts

Public ContactMasahiro Zako

Asai hospital Department of Ophthalmology

mzako@aol.com0561843111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026